Regulatory Pathways and Reimbursement Hurdles: Strategic Challenges Limiting the Full Commercial Potential of the Next Generation Sequencing Market.
The Next Generation Sequencing (NGS) market is not static; it is constantly evolving, with several cutting-edge technologies poised to define its next major growth phase. Among the most impactful of these new frontiers are single-cell sequencing and spatial genomics. Traditional NGS assays analyze DNA or RNA from bulk tissue samples, averaging the signals from thousands of cells. Single-cell...
0 Comments 0 Shares 645 Views 0 Reviews